Is temporal muscle thickness a survival predictor in newly diagnosed glioblastoma multiforme?

Aim Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. In this study, we aimed to show the relationship between temporal muscle thickness (TMT) measurement and survival in newly diagnosed patients with GBM. Methods Forty‐seven patients with newly diagnosed GBM...

Full description

Saved in:
Bibliographic Details
Published in:Asia-Pacific journal of clinical oncology 2020-10, Vol.16 (5), p.e223-e227
Main Authors: Yesil Cinkir, Havva, Colakoglu Er, Hale
Format: Article
Language:English
Subjects:
Brain tumors
Glioblastoma
Glioblastoma multiforme
Magnetic resonance imaging
Medical prognosis
Sarcopenia
Statistical analysis
Survival
temporal muscle
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. In this study, we aimed to show the relationship between temporal muscle thickness (TMT) measurement and survival in newly diagnosed patients with GBM. Methods Forty‐seven patients with newly diagnosed GBM were evaluated, retrospectively. TMT at diagnosis of GBM before any surgical procedure was measured on the contrast‐enhanced axial longitudinal relaxation time (T1)‐weighted magnetic resonance images. Overall survival (OS) was analyzed by the Kaplan‐Meier method and log‐rank test was used to determine the differences between the groups. The median TMT was used to determine the cutoff point. Results The median TMT was 4.7 mm (range, 2.8‐6.6) in females and 5.4 mm (range, 2.9‐8.1) in males. Median survival for TMT 
ISSN:1743-7555
1743-7563
DOI:10.1111/ajco.13369